Our studies illuminate a particular site of altered pyruvate utilization by liver mitochondria isolated from arsenic-fed rats. Initially, pyruvate dehydrogenase (PDH) levels were measured before and after in vitro activation. The liver homogenates were prepared from male rats given access to deionized drinking water solutions containing 0, 20, 40, and 85 ppm arsenic as sodium arsenate (As+5) for 3 and 6 weeks.
Introduction
Arsenic fed to laboratory animals is known to accumulate in the mitochondria which has been related to the swelling of this subcellular organelle in a number of tissues especially the liver (1) . In vitro research has demonstrated that arsenic affects mitochondrial oxidations by causing oligomycinsensitive stimulation of oxidation in the absence of inorganic phosphate (2, 3) and by stimulating the mitochondrial ATPase (4) . More recently, mitochondrial respiration studies, with liver mitochondria isolated from rats chronically exposed to arsenic, indicated decreased state 3 respiration rates and decreased respiratory control ratios for pyruvate/malate-but not succinate-mediated respiration (1) .
It has been suggested that the effects of arsenic on mitochondrial pyruvate utilization results from arsenic binding to the lipoic acid and dithiol moieties of the PDH complex (5 
Animals
The adult male Charles River CD rats used in this experiment were given access to a casein-based purified diet and to deionized drinking water containing 0, 20, 40, and 85 ppm arsenic as sodium arsenate (As+5) for 3 and 6 weeks. The animals were decapitated and hepatic tissue was excised quickly and dropped into liquid nitrogen. The frozen tissue samples were weighed and homogenized in ice cold buffer.
Assay of Pyruvate Dehydrogenase
The PDH activities were determined by the stoichiometric release of radioactive CO2 from [1-4C]-pyruvate by the method previously described (11) . This assay method was linear with time and protein concentration within the ranges utilized. The optimal in vitro activation conditions for PDH were determined to be exposure to 75mM MgCl2 at 37°C for 5 min. Aliquots of each tissue homogenate were assayed before and after Mg activation to determine the basal and total PDH activities, respectively.
Protein Analysis
Total protein concentrations in the homogenates were determined by procedures previously described (12) .
No mortality occurred among any of the treated animals during the course of the exposure to arsenic. A significant depression of growth rate was observed only among the animals exposed to the 85 ppm As+5 dose (1) .
The exposure of rats to arsenic for three weeks resulted in a decrease in both the basal and total hepatic PDH activities, as shown in Table 1 . The effects on the basal levels of PDH activity as compared to the controls indicated an increasing inhibition with dose level of 20, 23, and 48%. The total PDH levels were also lower, but by a smaller amount, i.e., 14, 15, and 28% (Table 1) . The PDH activity expressed as nmoles of CO2 liberated (pyruvate utilized) per minute per mg of protein is shown in Table 2 . The derived data in Table 2 illustrate another effect of arsenic. There was a decrease in the basal/total ratio with increasing arsenic dose level. The difference between the total and basal was relatively constant with increasing arsenic dose level. The ratio of the difference to the basal level went up markedly with increasing dose level, indicating the relative ease of activation increases with increasing dose level.
The effects after 6 weeks of arsenic exposure were inhibition of basal and total PDH activity. However, as shown in Table 3 , this inhibition was not observed at the highest dose level. 
